tradingkey.logo


tradingkey.logo


Caris Life Sciences Inc

CAI
27.940USD
+0.080+0.29%
終倀 12/19, 16:00ET15分遅れの株䟡
7.88B時䟡総額
損倱額盎近12ヶ月PER


Caris Life Sciences Inc

27.940
+0.080+0.29%

詳现情報 Caris Life Sciences Inc 䌁業名

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Caris Life Sciences Incの䌁業情報


䌁業コヌドCAI
䌚瀟名Caris Life Sciences Inc
䞊堎日Jun 18, 2025
最高経営責任者「CEO」Halbert (David Dean)
埓業員数- -
蚌刞皮類Ordinary Share
決算期末Jun 18
本瀟所圚地750 W. John Carpenter Freeway
郜垂IRVING
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号75039
電話番号18667718946
りェブサむトhttps://www.carislifesciences.com/
䌁業コヌドCAI
䞊堎日Jun 18, 2025
最高経営責任者「CEO」Halbert (David Dean)

Caris Life Sciences Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-2.76%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Vijay Mohan
Mr. Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Danny Phillips
Mr. Danny Phillips
Independent Director
Independent Director
--
--
Dr. Lloyd B. Minor, M.D.
Dr. Lloyd B. Minor, M.D.
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
J. Russel Denton
J. Russel Denton
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-2.76%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Vijay Mohan
Mr. Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Danny Phillips
Mr. Danny Phillips
Independent Director
Independent Director
--
--

収益内蚳

通貚: USD曎新時刻: Mon, Oct 6
通貚: USD曎新時刻: Mon, Oct 6
FY2025Q2
䌚瀟から関連デヌタがただ開瀺されおいたせん。
地域別USD
䌚瀟名
収益
比率
United States
178.18M
98.22%
International
3.22M
1.78%
事業別
地域別
䌚瀟から関連デヌタがただ開瀺されおいたせん。

株䞻

曎新時刻: Mon, Nov 17
曎新時刻: Mon, Nov 17
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Halbert (David D)
43.51%
Sixth Street Partners, LLC
8.64%
J.H. Whitney Capital Partners, LLC
7.18%
Castleman Peter M
3.68%
Coatue Management, L.L.C.
3.59%
他の
33.40%
株䞻統蚈
株䞻統蚈
比率
Halbert (David D)
43.51%
Sixth Street Partners, LLC
8.64%
J.H. Whitney Capital Partners, LLC
7.18%
Castleman Peter M
3.68%
Coatue Management, L.L.C.
3.59%
他の
33.40%
皮類
株䞻統蚈
比率
Individual Investor
48.47%
Investment Advisor
20.21%
Hedge Fund
11.05%
Private Equity
10.52%
Investment Advisor/Hedge Fund
4.85%
Pension Fund
0.53%
Research Firm
0.29%
Sovereign Wealth Fund
0.13%
Bank and Trust
0.08%
他の
3.86%

機関投資家保有株


曎新時刻: Wed, Jul 2
曎新時刻: Wed, Jul 2
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
172
130.04M
46.09%
+127.36M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Halbert (David D)
122.76M
43.65%
-141.96K
-0.12%
Aug 11, 2025
Sixth Street Partners, LLC
24.39M
8.67%
+24.39M
--
Jun 30, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.2%
+20.26M
--
Jun 30, 2025
Castleman Peter M
10.37M
3.69%
+10.34M
+32049.87%
Jun 18, 2025
Coatue Management, L.L.C.
10.14M
3.61%
+10.14M
--
Jun 30, 2025
Fidelity Management & Research Company LLC
8.61M
3.06%
+8.61M
--
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
7.30M
2.6%
+7.30M
--
Jun 30, 2025
Braidwell LP
7.32M
2.6%
+7.32M
--
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.76M
2.4%
+6.76M
--
Jun 30, 2025
Silver Lake Partners
5.29M
1.88%
+5.29M
--
Jun 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
ARK Genomic Revolution ETF
0.67%
Texas Capital Texas Small Cap Equity Index ETF
0.52%
Renaissance IPO ETF
0.43%
RiverNorth Patriot ETF
0.3%
Franklin Genomic Advancements ETF
0.29%
Invesco Russell 1000 Equal Weight ETF
0.08%
Inspire 500 ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.05%
Texas Capital Texas Equity Index ETF
0.04%
Fidelity Nasdaq Composite Index ETF
0.02%
詳现を芋る
ARK Genomic Revolution ETF
比率0.67%
Texas Capital Texas Small Cap Equity Index ETF
比率0.52%
Renaissance IPO ETF
比率0.43%
RiverNorth Patriot ETF
比率0.3%
Franklin Genomic Advancements ETF
比率0.29%
Invesco Russell 1000 Equal Weight ETF
比率0.08%
Inspire 500 ETF
比率0.07%
T Rowe Price Small-Mid Cap ETF
比率0.05%
Texas Capital Texas Equity Index ETF
比率0.04%
Fidelity Nasdaq Composite Index ETF
比率0.02%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Caris Life Sciences Incの䞊䜍5名の株䞻は誰ですか


Caris Life Sciences Incの䞊䜍5名の株䞻は以䞋のずおりです。
Halbert (David D)は122.76M株を保有しおおり、これは党䜓の43.65%に盞圓したす。
Sixth Street Partners, LLCは24.39M株を保有しおおり、これは党䜓の8.67%に盞圓したす。
J.H. Whitney Capital Partners, LLCは20.26M株を保有しおおり、これは党䜓の7.20%に盞圓したす。
Castleman Peter Mは10.37M株を保有しおおり、これは党䜓の3.69%に盞圓したす。
Coatue Management, L.L.C.は10.14M株を保有しおおり、これは党䜓の3.61%に盞圓したす。

Caris Life Sciences Incの株䞻タむプ䞊䜍3皮は䜕ですか


Caris Life Sciences Incの株䞻タむプ䞊䜍3皮は、
Halbert (David D)
Sixth Street Partners, LLC
J.H. Whitney Capital Partners, LLC

Caris Life Sciences IncCAIの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、Caris Life Sciences Incの株匏を保有しおいる機関は172瀟あり、保有株匏の総垂堎䟡倀は玄130.04Mで、党䜓の46.09%を占めおいたす。2025Q2ず比范しお、機関の持ち株は-23.14%増加しおいたす。

Caris Life Sciences Incの最倧の収益源は䜕ですか


FY2025Q2においお、--郚門がCaris Life Sciences Incにずっお最倧の収益を生み出しおおり、その金額は--で、党収益の--%を占めおいたす。
KeyAI
î™